Proper Patient Selection Yields Significant and Sustained Reduction in Systolic Blood Pressure Following Renal Artery Stenting in Patients With Uncontrolled Hypertension: Long-Term Results From the HERCULES Trial

Journal of Clinical Hypertension

Volumn 16, Issue 7, 2014, Pages 497-503

  Chrysant, George S ^a   Bates, Mark C ^b   Sullivan, Timothy M ^c   Bachinsky, William B ^d   Popma, Jeffrey J ^e   Peng, Lei ^f   Omran, Hend L ^f   Jaff, Michael R ^g  

^a INTEGRIS Heart Hospital   (United States)

^b West Virginia University School of Medicine Charleston   (United States)

^c MINNEAPOLIS HEART INSTITUTE FOUNDATION   (United States)

^d Harrisburg Hospital   (United States)

^e BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^f ABBOTT VASCULAR   (United States)

^g MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HEPARIN;

AGED; ANTIHYPERTENSIVE THERAPY; ARTERIOGRAPHY; ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEATH; DEVICE SAFETY; ECHOGRAPHY; FEMALE; HUMAN; HYPERTENSION; IN-STENT RESTENOSIS; INTERVENTIONAL CARDIOVASCULAR PROCEDURE; KIDNEY ARTERY EMBOLISM; KIDNEY ARTERY STENOSIS; KIDNEY FUNCTION; KIDNEY INJURY; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEPHRECTOMY; PATIENT SELECTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RENAL ARTERY; RENAL ARTERY STENT; RENAL ARTERY STENTING; SYSTOLIC BLOOD PRESSURE; UNCONTROLLED HYPERTENSION; BLOOD PRESSURE; BLOOD PRESSURE MEASUREMENT; CLINICAL TRIAL; FOLLOW UP; HYPERTENSION, RENOVASCULAR; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; RENAL ARTERY OBSTRUCTION; STENT; SURVIVAL; TREATMENT OUTCOME;

AGED; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BLOOD PRESSURE DETERMINATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION, RENOVASCULAR; MALE; MIDDLE AGED; PATIENT SELECTION; PROSPECTIVE STUDIES; RENAL ARTERY; RENAL ARTERY OBSTRUCTION; STENTS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84904110128     PISSN: 15246175     EISSN: 17517176     Source Type: Journal    
DOI: 10.1111/jch.12341     Document Type: Article

References (30)

1. Rocha-Singh K, Jaff MR, Rosenfield K; for the ASPIRE-2 Trial Investigators. Evaluation of the safety and effectiveness of renal artery stenting after unsuccessful balloon angioplasty: the ASPIRE-2 study. J Am Coll Cardiol. 2005;46:776-783.
2. Rocha-Singh K, Jaff MR, Lynne Kelley E. RENAISSANCE Trial Investigators. Renal artery stenting with noninvasive duplex ultrasound follow-up: 3-year results from the RENAISSANCE renal stent trial. Catheter Cardiovasc Interv. 2008;72:853-862.
3. Laird JR, Rundback J, Zierler RE, et al. Safety and efficacy of renal artery stenting following suboptimal renal angioplasty for de novo and restenotic ostial lesions: results from a nonrandomized, prospective multicenter registry. J Vasc Interv Radiol. 2010;21:627-637.
4. Zeller T, Frank U, Muller C, et al. Stent-supported angioplasty of severe atherosclerotic renal artery stenosis preserves renal function and improves blood pressure control: long-term results from a prospective registry of 456 lesions. J Endovasc Ther. 2004;11:95-106.
5. Blum U, Krumme B, Flugel P, et al. Treatment of ostial renal-artery stenoses with vascular endoprostheses after unsuccessful balloon angioplasty. N Engl J Med. 1997;336:459-465.
6. Watson PS, Hadjipetrou P, Cox SV, et al. Effect of renal artery stenting on renal function and size in patients with atherosclerotic renovascular disease. Circulation. 2000;102:1671-1677.
7. Dorros G, Jaff M, Jain A, et al. Follow-up of primary Palmaz-Schatz stent placement for atherosclerotic renal artery stenosis. Am J Cardiol. 1995;75:1051-1055.
8. Dorros G, Jaff M, Mathiak L, et al. Four-year follow-up of Palmaz-Schatz stent revascularization as treatment for atherosclerotic renal artery stenosis. Circulation. 1998;98:642-647.
9. Rodriguez-Lopez JA, Werner A, Ray LI, et al. Renal artery stenosis treated with stent deployment: indications, technique, and outcome for 108 patients. J Vasc Surg. 1999;29:617-624.
10. Gill KS, Fowler RC. Atherosclerotic renal arterial stenosis: clinical outcomes of stent placement for hypertension and renal failure. Radiology. 2003;226:821-826.
11. Lederman RJ, Mendelsohn FO, Santos R, et al. Primary renal artery stenting: characteristics and outcomes after 363 procedures. Am Heart J. 2001;142:314-323.
12. Dorros G, Jaff M, Mathiak L, He T. Multicenter Palmaz stent renal artery stenosis revascularization registry report: four-year follow-up of 1, 058 successful patients. Catheter Cardiovasc Interv. 2002;55:182-188.
13. Zeller T, Frank U, Muller C, et al. Predictors of improved renal function after percutaneous stent-supported angioplasty of severe atherosclerotic ostial renal artery stenosis. Circulation. 2003;108:2244-2249.
14. Kashyap VS, Sepulveda RV, Bena JF, et al. The management of renal artery atherosclerosis for renal salvage: does stenting help? J Vasc Surg. 2007;45:101-108.
15. Kalra PA, Chrysochou C, Green D, et al. The benefit of renal artery stenting in patients with atheromatous renovascular disease and advanced chronic kidney disease. Catheter Cardiovasc Interv. 2010;75:1-10.
16. Bates MC, Rashid M, Campbell JE, et al. Factors influencing the need for target vessel revascularization after renal artery stenting. J Endovasc Ther. 2006;13:569-577.
17. Bax L, Woittiez AJ, Kouwenberg HJ, et al. Stent placement in patients with atherosclerotic renal artery stenosis and impaired renal function: a randomized trial. Ann Intern Med. 2009;150:840, 8, W150-1.
18. Wheatley K, Ives N, Gray R, et al. for the ASTRAL Investigators. Revascularization versus medical therapy for renal-artery stenosis. N Engl J Med. 2009;361:1953-1962.
19. Cooper CJ, Murphy TP, Cutlip DE, et al. Stenting and medical therapy for atherosclerotic renal-artery stenosis. N Engl J Med 2014;370:13-22.
20. Schwarzwälder U, Hauk M, Zeller T. RADAR - a randomised, multi-centre, prospective study comparing best medical treatment versus best medical treatment plus renal artery stenting in patients with haemodynamically relevant atherosclerotic renal artery stenosis. Trials. 2009;10:60.
21. Rossi GP, Seccia TM, et al. The Medical and Endovascular Treatment of Atherosclerotic Renal Artery Stenosis (METRAS) study: rationale and study design. J Hum Hypertens. 2012;26:507-516.
22. Jaff MR, Bates M, Sullivan T, et al. Significant reduction in systolic blood pressure following renal artery stenting in patients with uncontrolled hypertension: results from the HERCULES trial. Catheter Cardiovasc Interv. 2012;80:343-350.
23. ICH Harmonised Tripartite Guideline E6: Note for Guidance on Good Clinical Practice. (PMP/ICH/135/95). European Medicines Agency, 2002.
24. Colyer WR Jr. RX Herculink Elite((R)) renal stent system: a review of its use for the treatment of renal artery stenosis. Med Devices (Auckl). 2012;5:67-73.
25. Chrysant SG. The current status of angioplasty of atherosclerotic renal artery stenosis for the treatment of hypertension. J Clin Hypertens (Greenwich). 2013;15:694-698.
26. Bonelli FS, McKusick M, Textor SC, et al. Renal artery angioplasty: technical results and clinical outcomes in 320 patients. Mayo Clin Proc. 1995;70:1041-1052.
27. Simon JF. Stenting atherosclerotic renal artery stenosis: time to be less aggressive. Cleve Clin J Med. 2010;27:178-189.
28. Dworkin LD. Controversial treatment of atherosclerotic renal vascular disease: the cardiovascular outcomes in renal atherosclerotic lesions trial. Hypertension. 2006;48:350-356.
29. Weinberg MD, Olin JW. Stenting for atherosclerotic renal artery stenosis: one poorly designed trial after another. Cleve Clin J Med. 2010;27:164-171.
30. Weinberg I, Keyes MJ, Giri J, et al. Blood pressure response to renal artery stenting in 901 patients from five prospective multicenter FDA-approved trials. Catheter Cardiovasc Interv. 2014;83:603-609.